Skip to main content

Universal Technical Institute I (UTI) Stock Analysis

Breakout setup

SellVALUE-TRAP 2/5Moderate Confidence

Consumer Defensive · Education & Training Services

Sell if holding. Analyst target reached at $39.17 — A.R:R is negative (-0.4) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%).

Universal Technical Institute operates two post-secondary education divisions: UTI (15 campuses for transportation/skilled trades/energy) and Concorde Career Colleges (17 campuses for healthcare programs) serving students nationwide. Revenue comes from student tuition funded... Read more

$39.17+4.0% A.UpsideScore 4.2/10#15 of 15 Education & Training Services
QualityF-score6 / 9FCF yield1.24%
Stop $36.40Target $40.70(resistance)A.R:R -0.4:1
Analyst target$42.50+8.5%6 analysts
$40.70our TP
$39.17price
$42.50mean
$38
$49

Sell if holding. Analyst target reached at $39.17 — A.R:R is negative (-0.4) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%). Chart setup: Golden cross, above all MAs, RSI 61, MACD bullish. Score 4.2/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

Recent Developments — Universal Technical Institute I

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards
Sector modifier (Consumer Defensive): +0.8
Strong earnings beat streak (3/4)
Risks
Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%)
Analyst target reached - limited upside remaining
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4)

Key Metrics

P/E (TTM)52.1
P/E (Fwd)42.5
Mkt Cap$2.2B
EV/EBITDA25.9
Profit Mgn4.9%
ROE13.5%
Rev Growth6.7%
Beta1.28
DividendNone
Rating analysts11

Quality Signals

Piotroski F6/9MoatNarrow

Concentration Risks(10-K Item 1A)

  • HIGHregulatoryTitle IV Programs and veterans' programs78%
    10-K Item 1A: 'including Title IV Programs and veterans’ programs, from which we derived approximately 78% of our revenues, on a cash basis, in fiscal 2025'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.0
Revenue Growth
4.2

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
1.8
Quality Rank
3.5
Growth Rank
4.0

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda
0.0
Pe
2.4
Forward Pe
2.7
Peg Ratio
3.6
Analyst Target
4.0
Ps
8.6
Forward P/E: 42.5xPEG: 3.14
GatesA.R:R -0.4=NEGATIVEMomentum 6.8>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 79d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
61 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $31.42Resistance $41.53

Price Targets

$36
$41
A.Upside+3.9%
A.R:R-0.4:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Target reached (-5.5% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-05 (79d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UTI stock a buy right now?

Sell if holding. Analyst target reached at $39.17 — A.R:R is negative (-0.4) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%). Chart setup: Golden cross, above all MAs, RSI 61, MACD bullish. Prior stop was $36.40. Score 4.2/10, moderate confidence.

What is the UTI stock price target?

Take-profit target: $40.70 (+4.0% upside). Prior stop was $36.40. Stop-loss: $36.40.

What are the risks of investing in UTI?

Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%); Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4).

Is UTI overvalued or undervalued?

Universal Technical Institute I trades at a P/E of 52.1 (forward 42.5). TrendMatrix value score: 3.5/10. Verdict: Sell.

What do analysts say about UTI?

11 analysts cover UTI with a consensus score of 4.1/5. Average price target: $43.

What does Universal Technical Institute I do?Universal Technical Institute operates two post-secondary education divisions: UTI (15 campuses for...

Universal Technical Institute operates two post-secondary education divisions: UTI (15 campuses for transportation/skilled trades/energy) and Concorde Career Colleges (17 campuses for healthcare programs) serving students nationwide. Revenue comes from student tuition funded predominantly by Title IV Programs and veterans' benefits, which together represented ~78% of fiscal 2025 cash revenues.

Related stocks: TAL (TAL Education Group) · EDU (New Oriental Education & Techno) · PRDO (Perdoceo Education Corporation) · LAUR (Laureate Education, Inc.) · COUR (Coursera, Inc.)